Columbia’s Dian Yang is placing CRISPR-based molecular recorders into cancer cells to eavesdrop on cancer evolution and pinpoint when and how cells metastasize.
Misinformation and outdated beliefs about screening tests, treatment options, and effects on sexual health continue to cloud understanding about this disease.
The Columbia community gathered in the Hudson Valley for the eighth annual Velocity: Columbia’s Ride to End Cancer. This year’s event raised more than $1 million and attracted nearly 600 participants.
Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
After skin cancer, prostate cancer is the most common cancer diagnosed among men in the United States, and about one in eight men will be diagnosed with the disease during their lifetime.
Jill Biden and Queen Letizia learned about the cancer center's work to transform care, improve diversity and access in clinical trials, and promote diversity and inclusion in science and medicine.
As part of the Biden Administration's Cancer Moonshot initiative, First Lady Jill Biden and Queen Letizia of Spain visited Columbia University's cancer center on Sept. 21.
The symposium will feature keynotes by Margaret Foti, chief executive at AACR, and Ned Sharpless, former director of the NCI, along with talks from leading members of the cancer center.
Columbia researchers have found that a protein released by multiple myeloma cells prevents the immune system from attacking the cancer, a finding that could lead to better treatments.
Researchers have found why cancer cells in oxygen-depleted environments are forced to rely on fat imports, a finding that could lead to new ways to understand and slow down tumor growth.